We have located links that may give you full text access.
Race and Socio-Economic Status Impact Withdrawal of Treatment in Young Traumatic Brain Injury.
Journal of Pain and Symptom Management 2024 August 1
CONTEXT: Withdrawal of life-sustaining therapies (WDLST) in young individuals with traumatic brain injury (TBI) is an overwhelming situation often made more stressful by socioeconomic factors that shape health outcomes. Identifying these factors is crucial to developing equitable and goal-concordant care for patients and families.
OBJECTIVES: We aimed to identify predictors of WDLST in young patients with TBI. We hypothesized uninsured payment method, race, and co-morbid status are associated with WDLST.
METHODS: We queried the 2021 Trauma Quality Improvement Program database for patients <45 years with TBI. Patients with WDLST were compared to patients without WDLST. Multivariable logistic regression (MLR) was performed.
RESULTS: 61,115 patients were included, of whom 2,487 (4.1%) underwent WDLST. Patients in the WDLST cohort were older (29 vs 27,p<0.001), more likely to suffer from a penetrating mechanism (29% vs 11%,p<.0001), and have uninsured (22% vs 18%) or other payment method (5% vs 3%) when compared to the non-WDLST cohort. MLR identified age (AOR:1.019, 95%CI 1.014-1.024, p<.0001), non-Hispanic ethnicity (AOR:1.590, 95%CI 1.373-1.841,p<.0001), penetrating mechanism (AOR:3.075, 95%CI 2.727-3.467,p<.0001), systolic blood pressure (AOR: 0.992, 95%CI 0.990-0.993,p<0.0001), advanced directive (AOR:4.987, 95%CI 2.823-8.812,p<.0001), cirrhosis (AOR:3.854, 95%CI 2.641-5.625,p<.0001), disseminated cancer (AOR:6.595, 95%CI 2.370-18.357,p=0.0003), and interfacility transfer (AOR:1.457, 95%CI 1.295-1.640,p<0.0001) as factors associated with WDLST. Black patients were less likely to undergo WDLST when compared to white patients (AOR:0.687, 95%CI 0.603-0.782,p<.0001).
CONCLUSION: The decision for WDLST in young patients with severe TBI may be influenced by cultural and socioeconomic factors in addition to clinical considerations.
OBJECTIVES: We aimed to identify predictors of WDLST in young patients with TBI. We hypothesized uninsured payment method, race, and co-morbid status are associated with WDLST.
METHODS: We queried the 2021 Trauma Quality Improvement Program database for patients <45 years with TBI. Patients with WDLST were compared to patients without WDLST. Multivariable logistic regression (MLR) was performed.
RESULTS: 61,115 patients were included, of whom 2,487 (4.1%) underwent WDLST. Patients in the WDLST cohort were older (29 vs 27,p<0.001), more likely to suffer from a penetrating mechanism (29% vs 11%,p<.0001), and have uninsured (22% vs 18%) or other payment method (5% vs 3%) when compared to the non-WDLST cohort. MLR identified age (AOR:1.019, 95%CI 1.014-1.024, p<.0001), non-Hispanic ethnicity (AOR:1.590, 95%CI 1.373-1.841,p<.0001), penetrating mechanism (AOR:3.075, 95%CI 2.727-3.467,p<.0001), systolic blood pressure (AOR: 0.992, 95%CI 0.990-0.993,p<0.0001), advanced directive (AOR:4.987, 95%CI 2.823-8.812,p<.0001), cirrhosis (AOR:3.854, 95%CI 2.641-5.625,p<.0001), disseminated cancer (AOR:6.595, 95%CI 2.370-18.357,p=0.0003), and interfacility transfer (AOR:1.457, 95%CI 1.295-1.640,p<0.0001) as factors associated with WDLST. Black patients were less likely to undergo WDLST when compared to white patients (AOR:0.687, 95%CI 0.603-0.782,p<.0001).
CONCLUSION: The decision for WDLST in young patients with severe TBI may be influenced by cultural and socioeconomic factors in addition to clinical considerations.
Full text links
Related Resources
Trending Papers
Prevention and management of venous thrombosis in patients with cirrhosis.British Journal of Haematology 2024 August 26
Clinical Evaluation and Management of Thrombotic Microangiopathy.Arthritis & Rheumatology 2024 Februrary
Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management.American Journal of Hematology 2024 September 6
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app